Corporate Presentation

Similar documents
Corporate Presentation

CSE:CRZ 1 OTCQX:CNNRF

Corporate Presentation

Corporate Presentation April 2017 CSE: CRZ OTCQB: CNNRF

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS. For the three months ended March 31, 2018 and March 31, 2017 (Expressed in Canadian Dollars)

CREATING A NORTH AMERICAN CANNABIS POWERHOUSE APRIL 2019

DISCLAIMER STATEMENTS

DISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2

Nurturing Shareholder Growth

QUARTERLY REPORT. For the three and six months ended June 30, 2017 and June 30, (Expressed in Canadian Dollars)

DISCLAIMER STATEMENTS

STRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT

Canopy Growth to Acquire Hiku Brands to Strengthen Retail and Brand Portfolio

CONSOLIDATED FINANCIAL STATEMENTS. For the year ended December 31, 2017 and the nine-months ended December 31, 2016 (Expressed in Canadian Dollars)

Golden Leaf Reports Fiscal First Quarter 2018 Results

Emerald Health Therapeutics Reports 1 st Quarter 2018 Financial Results and Provides Corporate Update

ianthus Capital Holdings, Inc. CNSX: IAN OTCQB: ITHUF

Cannex - CSE: CNNX OTCQX: CNXXF. A Perfect Match.

General. Forward-Looking Statements

DISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2

INVESTOR PRESENTATION. June 01, 2018 CSE: CALI OTCQB: FNNZF

General. Forward-Looking Statements

GLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION

Scythian Biosciences Makes Strategic Investment in Verano Holdings with $188 Million USD Transaction

Overview September, 2018

PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT

BLISSCO CANNABIS CORP. MANAGEMENT DISCUSSION AND ANALYSIS Nine Months Ended October 31, 2018

Global Leader in Medical Cannabis Created by Aphria & Nuuvera Combination. January 29, 2018

Liberty Health Sciences

CORPORATE PRESENTATION CANADA S CANNABIS COMPANY

CORPORATE PRESENTATION

Curaleaf Reports Third Quarter 2018 Financial and Operational Results

EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017

Investor Presentation January CSE ticker: GW

Namaste Technologies Inc. Management Discussion and Analysis Three and six months ended February 28, 2018

CORPORATE PRESENTATION

Investor Presentation

CANNAROYALTY CORP. CSE FORM 2A LISTING STATEMENT in connection with the listing of CannaRoyalty Corp., the entity formed upon the reverse take-over of

Introduction to Nature s Way Management Group Inc.

Overview September, 2018

Investor Presentation. TSX Venture (OGI) OTCQX Best Market (OGRMF)

ianthus Capital Acquires Medical Cannabis Business of GrowHealthy Holdings, Marking Full-Scale Entry into Fast Growing Florida Market

DRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Founder, Chairman & Co-CEO November 2018

TSX:LEAF Investor Presentation December 2017 Top Licensed Producer

It is with confidence that the Company provides a summarized update on its projects.

DISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2

DOJA Cannabis Company Limited (Formerly SG Spirit Gold Inc.)

DRIVING THE GLOBAL CANNABIS INDUSTRY. February 2019

Automotive Finco Corporation

TSX:LEAF Investor Presentation October 2017

Investor Presentation August 23, 2017

BUILDING THE FIRST TRUE CANNABIS CPG PLATFORM DIXIE BRANDS INC. INVESTOR PRESENTATION Q CSE: DIXI.U

SIR Royalty Income Fund. Investor Presentation (TSX: SRV.UN) July 2018

Corporate Presentation November 2017

SIR Royalty Income Fund. Investor Presentation (TSX: SRV.UN) April 2018

TSX:LEAF Investor Presentation March 2018

GRENVILLE STRATEGIC ROYALTY CORP. INVESTOR PRESENTATION May 31, 2016

B. Riley FBR Conference May 23, 2018

( TEST TSX-V) Ultra Sensitive Cannabis Testing

I n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s

FORM 8-K. TERRA TECH CORP. (Exact name of registrant as specified in its charter)

FastForward Innovations Limited. ( FastForward ) Investee Company Update:

ASTAR MINERALS LTD. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE THREE MONTHS ENDED JULY 31, 2017

Expressed in United States Dollars

Corporate Presentation March 2018

Founders Advantage Capital Corp. Announces Letter of Intent to Acquire Full Ownership of Dominion Lending Centres; Announces Management Changes

DRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Chairman, Founder & Co-CEO February 2019

Zenabis November 21, 2018

DRIVING THE GLOBAL CANNABIS INDUSTRY. February 2018

CANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, Stated in Canadian Funds

DRIVING THE GLOBAL CANNABIS INDUSTRY

Target Capital Inc. Announces Recapitalization Financing and New Management Team and Board of Directors

FORM 7 MONTHLY PROGRESS REPORT FOR THE MONTH ENDED MARCH 31, MPX Bioceutical Corporation ( MPX or the Issuer ).

POCML 4 INC. Management s Discussion and Analysis. (a Capital Pool Corporation) For the Quarter Ended: March 31, Date of Report: May 30, 2018

CSE: MDM FSE: 2M0 OTCQB: MRPHF. December 27th, 2017, Kelowna, BC. Marapharm Ventures Inc. updates Las Vegas cannabis facility

Q Supplementary Information

Entegris and Versum Materials Merger of Equals

EMERALD HEALTH THERAPEUTICS, INC.

TSX-Venture Exchange: RRL

LOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY

Aurora Cannabis and Liquor Stores N.A. Announce Investment to Develop Western Canadian Retail Cannabis Business

This presentation contains forward-looking information within the meaning of applicable Canadian securities legislation, including management s

Investor Presentation April 2017

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018

EMERALD HEALTH THERAPEUTICS, INC.

E N WAV E C O R P O R AT I O N C O R P O R A T E P R E S E N T A T I O N

OSISKO AND VIRGINIA ANNOUNCE BUSINESS COMBINATION TO CREATE A LEADING INTERMEDIATE GOLD ROYALTY COMPANY

Management s Discussion and Analysis

FORM F3 MATERIAL CHANGE REPORT

Condensed Interim Consolidated Financial Statements

Terra Tech, Jumping into the California Retail Cannabis Market, Analysts Target Price

Presented by: Eric Paul & Brad Rogers

Biosenta Inc. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE THREE MONTHS ENDED DECEMBER 31, 2014 AND 2013

Q INVESTOR PRESENTATION. A Global Cannabis Leader

A digital financial brand for the next generation of Canadians

Liberty Health Sciences Inc. (formerly, SecureCom Mobile Inc.)

MM DEVELOPMENT COMPANY, LLC

Transcription:

Corporate Presentation April 2018 CSE: CRZ OTCQX: CNNRF

INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking information regarding CannaRoyalty Corp. ( CannaRoyalty or the Company ) and its subsidiaries. Except for statements of historical fact, certain information contained herein constitutes forward-looking statements which include management s assessment of future plans and operations and are based on current internal expectations, estimates, projections, assumptions and beliefs, which may prove to be incorrect. Often, but not always, forward-looking statements can be identified by the use of words and phrases such as plans, expects, is expected, budget, scheduled, estimates, forecasts, intends, anticipates, or believes or variations (including negative variations) of such words and phrases, or statements that certain actions, events or results may, could, would, might or will be taken, occur or be achieved. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and are based on various assumptions such as: (i) the Company s ability to generate cash flow from operations and obtain necessary financing on acceptable terms; (ii) general economic, financial market, regulatory and political conditions in which the Company operates; (iii) consumer interest in Company products; (iv) anticipated and unanticipated costs; (v) government regulation of the Company s activities and products; (vi) the timely receipt of any required regulatory approvals; (vii) the Company s ability to obtain qualified staff, equipment and services in a timely and cost efficient manner; the Company s ability to conduct operations in a safe, efficient and effective manner; (viii) and the Company s construction plans, expansion of facilities, its costs and timeframe for completion of such plans. Forward-looking statements are not guarantees of future performance and undue reliance should not be placed on them. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaRoyalty to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Many of these risk factors and uncertainties are discussed in the Company s Annual Information Form in a section entitled Risk Factors and other documents the Company files with the Canadian Securities Administrators available on SEDAR at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this Presentation and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results, except as may be required by applicable securities laws. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Securities Laws This Presentation is for informational purposes and does not constitute an offer or a solicitation of an offer to purchase the securities referred to herein. No Reproduction or Distribution The contents of this presentation are not to be reproduced or distributed to any third party, including the general public or the media, without the express written consent of CannaRoyalty. The information contained herein, while obtained from available sources which the Company believes are reliable, is not guaranteed as to its accuracy or completeness. Third Party Information Certain information contained in this Presentation with respect to market trends and products has been obtained or quoted from publicly available sources, such as continuous disclosure documents, independent publications, media articles, third party websites (collectively, the Publications ). In certain cases, these sources make no representations as to the reliability of the information they publish. Further, the analyses and opinions reflected in these Publications are subject to a series of assumptions about future events. There are a number of factors that can cause the results to differ materially from those described in these publications. None of the Company or its representatives independently verified the accuracy or completeness of the information contained in the Publications or assume any responsibility for the completeness or accuracy of the information derived from these Publications. Additional Information Additional information relating to the Company has been filed electronically through SEDAR and is available online at www.sedar.com or at the Company s website at www.cannaroyalty.com. 1

Business Overview INVESTMENT TYPES Royalty Agreements Equity Stakes Canada Licensing Deals Secured & Convertible Debt Other Strategic Partnerships 6 US States (CA, WA, AZ, FL, NV) BUSINESS SEGMENTS 19 CR Holdings Puerto Rico CR Advisory Services CR Brands 2

Value-add Segments in a Familiar Industry ~ 10% ~ 90% Barley, hops, yeast Seeds & Genetics Cultivation a Downstream value Testing & Research Extraction Product Development & Design Production Distribution & Logistics Branding & Packaging Retail & Sales Marketing & Consumer Engagement 3

CR HOLDINGS CR BRANDS CR ADVISORY SERVICES Building a premium suite of branded cannabis consumer products, supported by existing and growing portfolio of strategic manufacturing & distribution assets. 4

CR BRANDS 5

CR BRANDS REF: 1. ARCVIEW 2. BRIGHTFIELD GROUP 3. NEW FRONTIER DATA 4. HEALTH CANADA 5. MARIJUANA POLICY PROJECT 6

Foundational Strength Leading California Cannabis Distributor Two 100%-owned leading distribution companies access to vast majority of licensed dispensaries statewide Distribution is a unique competitive advantage CR BRANDS All licensed dispensaries in California are required to source products exclusively through licensed distributors More than distribution ensure product safety and tax collection Ideal partner for new/existing brands looking to enter California market at scale Carefully selected portfolio of manufacturing partners - superior partner for dispensaries seeking one-stop access to a full spectrum of top products and brands, in an efficient and cost-effective manner 7

Strategic California Brand Platform as of Q1 2018 Advanced vaping hardware, and owns GreenRock Botanical vape brand. 100% equity ownership Award-winning, gourmet quality edibles brand growing menu of products on offer. 100% equity ownership CR BRANDS Licensing rights for premium quality, smoke-free wellness products. Equity interest in parent co., royalty, exclusive license rights certain US states & Canada Award-winning vape, edibles & concentrate lines established, leading brand Exclusive statewide manufacturing and distribution rights Leading technology for mass pre-roll production, white-label and in house brands. Equity interest, exclusive right to IP & technology for Canada 1 100% family owned and operated cultivator in Northern California that handcrafts, brands and packages small batches of ultra-premium cannabis flower 100% equity ownership 1 Subject to closing Distribution backbone = immediate scale, speed to market and superior product development intelligence 8

Vape Pen Product Category CR BRANDS 9

Edible Product Category CR BRANDS 11

Ultra-premium, Branded Cannabis Flower and Products 1 CR BRANDS 1 Subject to closing 12

Leveraging the U.S. Platform On December 13, 2017, CannaRoyalty signed a binding Letter of Intent with Aurora Cannabis Inc. ( Aurora ) giving Aurora the exclusive right to negotiate a final licensing agreement for Canada, Europe and Australia to the intellectual property, manufacturing procedures, and the sales and marketing rights related the award-winning MüV brand. MüV is an award-winning science focused cannabis consumer brand that is focused on developing outstanding, consistent, and pure cannabis-based branded products CR BRANDS In March 2018, CannaRoyalty further expanded its Canadian distribution and retail reach through NAC. The two companies entered into a new agreement to grant preferential product access to CR Brands products across NAC s Canadian network of retail cannabis stores, in anticipation of full-adult use legalization approaching 13

CR HOLDINGS 14

CR Holdings CR HOLDINGS 1 1 Subject to closing 15

CR ADVISORY SERVICES 16

Service Offerings Capital Markets & Finance Marketing & Brand Development FOCUSED ON Operational Support Compliance & Regulatory CR ADVISORY SERVICES CR Holdings Paid service offerings provided to our investee companies Functional knowledge and industry expertise to accelerate growth and improve returns Secured engagements with investees AltMed, Wagner Dimas, Anandia including third parties such as Planet 13, a leading vertically-integrated Las Vegas cannabis company. 17

Advisory Services Trichome provides secured debt financing to Canadian and global cannabis companies, and aspires to be a yieldoriented asset backed investment opportunity for investors. On March 14 th Trichome signed its first deal, to provide up to $2.5 million to 180 Smoke, a leading Canadian online and retail vaporizer products company. The capital will enable 180 Smoke to fund an expansion of its retail footprint in anticipation of Canadian adult-use cannabis legalization. In February 2018, CannaRoyalty announced the appointment of proven financial, M&A and cannabis-industry professionals Afzal Hasan, Dr. Jonathan Page, Marissa Lauder and Timothy Diamond to the Board of Directors of Trichome Yield Corp. CR ADVISORY SERVICES 18

CSE: CRZ OTCQX: CNNRF 19

Management Team The Board of Directors Dr. James F. Young, PhD 30 years in pharmaceutical development Chairman, Novavax, Inc. (Nasdaq:NVAX) Marc Lustig CEO, Director 16+ years in healthcare, capital markets. Francois Perrault CFO 25+ years of senior financial experience. Afzal Hasan EVP, Corporate Development Broad experience with public listings and prospectus financing. Corporate Development Team Dave Vautrin VP, Sales and Marketing 20+ years consumer product goods operational experience. Rob Harris 35+ years in Canada/US pharmaceutical industry CEO of Tribute Pharmaceuticals Peter Kampian 30 years of senior financial and corporate governance expertise CFO of Mettrum Health Corp when it was acquired by Canopy Growth Chair of CannaRoyalty audit committee Oskar Lewnowski 20 years of experience as a leading global resource financier, company- founder and Chief Investment Officer of Orion Resource Partners Kevin Jarrett VP, Investments Michael Garbuz Corporate Strategy & Legal Counsel Thomas J. Finch Senior Financial Analyst Marc Lustig CannaRoyalty CEO Significant experience investing in private and public North American growth companies. Next-generation cannabis industry strategist. 8+ years in capital markets, investment banking. 20

51.27mm SHARES OUTSTANDING Dilutive securities: Capital Structure 4.08mm incentive RSUs issued and outstanding, including 2.30mm currently vested 0.88mm share options with exercise prices largely at $3.73/share 0.75mm shares ($1.5mm convertible debt with Aphria Inc., convertible at $2/share) 3.73mm warrants, exercisable at between $3.00-4.00/share 2.09mm warrants, exercisable at $4.50/share 2.16mm warrants, exercisable at $5.50/share CSE: CRZ OTCQX: CNNRF 61.96mm FULLY DILUTED SHARES Previous financings: 04/15-10/15: C$2.1mm @ C$0.50/share 03/16: C$2.5mm @ C$0.75/share 06/16-07/16: C$4.7mm @ C1.00/unit 10/16 (RTO): C$5.0mm @ C$2.00/share 02/17: C$15mm bought deal financing @ C$3.00/unit 04/18: C$17.2mm bought deal financing @ C$4.00/unit C$10mm bridge capital available from Sprott Inc. Insider ownership ~8% (all subject to Lock-up/CSE Escrow) Insider + Acquired Assets + Strategic Corporate (Aphria) + Family Office + Institutional ownership > 80% 21

- Diversified Holdings - - Revenue Growth & Cash Flow - - Growing Portfolio of Premium Brands - - Distinct Business Model - CSE: CRZ OTCQX: CNNRF 22